Create Alert
Watchlist

Aarti Drugs

₹452.00
+5.20 (1.16%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
446.80
Prev. Close
446.80
Volume
67,162
Total traded value
3.04 Cr
Upper Circuit
536.15
Lower Circuit
357.45

Fundamentals

Market Cap₹4,109Cr
ROE13.56%
P/E Ratio(TTM)20.66
EPS(TTM)21.64
P/B Ratio2.80
Dividend Yield0.22%
Industry P/E33.24
Book Value159.78
Debt to Equity0.39
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Aarti Drugs

Established in 1984, Aarti Drugs Limited is a prominent player in the pharmaceutical industry, well-positioned for future market growth. Its vision is to become the first-choice vendor for bulk drugs by providing customized solutions and services to meet the changing requirements of customers. The company's mission is to seek global market leadership and strive for excellence in customer service, quality, and R&D. It specializes in manufacturing active pharmaceutical ingredients (APIs), specialty chemicals, and intermediates across various therapeutic categories like antibiotics and anti-diabetics. Through its wholly-owned subsidiary, Pinnacle Life Sciences Private Limited, the company also manufactures advanced formulations, playing a pivotal role in its revenue generation. Aarti Drugs is one of the world's leading producers of Metformin and the largest producer of Metronidazole in India, showcasing its market leadership.;
Parent OrganisationAarti Drugs Limited
Managing DirectorShri Prakash M. Patil
NSE SymbolAARTIDRUGS

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
54.72%
Retail And Others
32.69%
Mutual Funds
9.81%
Foreign Institutions
2.69%
Other Domestic Institutions
0.09%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Divi's Laboratories
NA
(0.00%)
69.05
Neuland Laboratories
NA
(0.00%)
89.31
Jubilant Pharmova
NA
(0.00%)
36.27
Acutaas Chemicals
NA
(0.00%)
62.86